Holly Wobma, MD, Ph.D., Instructor of Pediatrics, Harvard Medical School. Dr. Wobma will be studying CAR-Treg's capacity to ...

Cutaneous lupus erythematosus is a chronic autoimmune disease with few treatment options and no approved targeted therapies.

In a study published in the Annals of the Rheumatic Diseases researchers found that compounds detected in exhaled breath may offer a promising, noninvasive way to better understand and monitor ...

Parallel Spherix Global Insights studies reveal expanding biologic use and evolving treatment strategies have yet to fully translate into durable disease control and improved quality of life for many ...

Natural killer cells are a type of immune cell involved in lupus. (JUAN GAERTNER/SCIENCE PHOTO LIBRARY/Getty Images) Lupus ...

Scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus) and show that reversing this defect may potentially reverse ...

Scientists may have pinpointed a primary cause of lupus, a chronic autoimmune disease. Researchers from Northwestern Medicine in Chicago and Brigham and Women’s Hospital in Boston claim they have ...

Objective Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly recognised for benefits beyond glycaemic ...

More than 50% of patients with systemic lupus erythematosus (SLE) experienced flare and nearly 50% had persistently active disease, whereas some had persistently active disease without flare. Both ...

Autoimmune diseases affect millions of people worldwide and are becoming increasingly common. Conditions such as lupus, rheumatoid arthritis, type 1 diabetes, multiple sclerosis, and Hashimoto's ...

Eventual tapering and withdrawal of steroids in patients with lupus nephritis is recommended to minimize the drugs' adverse effects, but the ideal timing is uncertain. This study followed 136 lupus ...